Intermittent blood flow in solid tumours - An under-appreciated source of 'drug resistance'

Cancer and Metastasis Reviews

Volumn 20, Issue 1-2, 2001, Pages 57-61

  Durand, Ralph E ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

Blood flow; Chemotherapy; Resistance; Solid tumours

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RESISTANCE; CANCER SURVIVAL; CANCER THERAPY; CELL GROWTH; DRUG DELIVERY SYSTEM; HUMAN; PRIORITY JOURNAL; SOLID TUMOR; TUMOR BLOOD FLOW;

ANTINEOPLASTIC AGENTS; BLOOD FLOW VELOCITY; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; REGIONAL BLOOD FLOW;

EID: 0035694958     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013181107707     Document Type: Article

References (50)

1. Hypoxia in tumors: A paradigm for the approach to biochemical and physiologic heterogeneity
2. Tumour hypoxia: The picture has changed in the 1990s
3. Tumor oxygenation: A matter of supply and demand
4. The lifetime of hypoxic human tumor cells
5. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice
6. Review article: Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy
7. Therapeutic implications of tumor physiology
8. Lack of general correlation between interstitial fluid pressure and oxygen partial pressure in solid tumors
9. In vivo observations of tumor blood flow
10. ATP synthesis during low-flow ischemia: Influence of increased glycolytic substrate
11. Unifying theory of hypoxia tolerance: Molecular/metabolic defense and rescue mechanisms for surviving oxygen lack
12. Quiescence in Artemia franciscana embryos: Reversible arrest of metabolism and gene expression at low oxygen levels
13. Intermittent blood flow in a murine tumor: Radiobiological effects
14. The use of fluorescent probes to identify regions of transient perfusion in murine tumors
15. Contribution of transient blood flow to tumour hypoxia in mice
16. Tumour blood flow influences combined radiation and doxorubicin treatments
17. Acute hypoxia in tumors: Implications for modifiers of radiation effects
18. Determination of local oxygen consumption rates in tumors
19. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
20. Blood flow and tissue oxygenation of human tumors: An update
21. Pretreatment oxygenation profiles of human soft tissue sarcomas
22. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
23. Comparison between the comet assay and the oxygen microelectrode for measurement of tumor hypoxia
24. Microregional blood flow in murine and human tumours assessed using laser Doppler microprobes
25. Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry
26. In vivo labelling with halogenated pyrimidines of squamous cell carcinomas and adjacent non-involved mucosa of head and neck region
27. Comparative analysis of different approaches to investigate cell kinetics
28. Proliferation assays in prognosis of cancer
29. Cell and environment interactions in tumor microregions: The multicell spheroid model
30. Spheroids in radiobiology
31. Multicellular resistance: A new paradigm to explain aspects of acquired drug resistance of solid tumors
32. Drug and radiation resistance in spheroids: Cell contact and kinetics
33. Cell adhesion and drug resistance in cancer
34. Multicellular membranes as an in vitro model for extravascular diffusion in tumours
35. Multilayers of cells growing on a permeable support. An in vitro tumour model
36. The influence of expression of P-glycoprotein on the penetration of anti-cancer drugs through multicellular layers of solid tissue
37. Measurement of delivery and metabolism of tirapazamine to tumour tissue using the multilayered cell culture model
38. The growth fraction: A new concept applied to tumors
39. Cell proliferation measurements by bromodeoxyuridine or thymidine incorporation: Clinical correlates
40. Cell kinetics and repopulation parameters of irradiated xenograft tumours in SCID mice: Comparison of two dose-fractionation regimens
41. Repopulation characteristics and cell kinetic parameters resulting from multi-fraction irradiation of xenograft tumors in SCID mice
42. Tumor repopulation during radiotherapy: Quantitation in two xenografted human tumors
43. Regrowth resistance in cancer: Why has it been largely ignored?
44. Repair and proliferation: Major determinants of the multifraction radiation response
45. Tumor resistance to therapy: A genetic or kinetic problem?
46. Cell kinetics and repopulation during multifraction irradiation of spheroids: Implications for clinical radiotherapy
47. Multicell spheroids as a model for cell kinetics studies
48. Less is more, regularly: Metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice
49. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity